Biothera, Inc., a biotechnology company, develops a natural gluco polysaccharide that engages and directs natural innate immune systems. Biothera was formerly known as Biopolymer Engineering, Inc. and changed its name to Biothera, Inc. in March 2005. The company was founded in 1997 and is based in Eagan, Minnesota.

Seattle Genetics is a clinical-stage biotechnology company that focuses on developing and commercializing monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Its lead product, SGN-35, is in the pivotal trial for patients with relapsed or refractory Hodgkin lymphoma. The company's other product candidates in various stages of clinical trials include dacetuzumab (SGN-40), a humanized anti-CD40 antibody; lintuzumab (SGN-33), a humanized anti-CD33 antibody; SGN-70, a humanized anti-CD70 antibody for the treatment of autoimmune diseases; SGN-75, which is in Phase I clinical trials for metastatic renal cell carcinoma and non-Hodgkin lymphoma; ASG-5ME, a preclinical antibody-drug conjugate product candidate for the treatment of solid tumors; and SGN-19A, a preclinical antibody-drug conjugate product candidate for the treatment of hematologic malignancies. It has collaborations with Bayer Pharmaceuticals Corporation; Celldex Therapeutics, Inc.; Daiichi Sankyo Co., Ltd.; Genentech; GlaxoSmithKline LLC; MedImmune, Inc.; Millennium; PSMA Development Company LLC; and Genmab A/S. The company also has an antibody-drug conjugates co-development agreement with Agensys, Inc. The company was founded in 1997 and is headquartered in Bothell, Washington.

Yicester (Beijing) Pharmaceutical Technology Development Co., Ltd., established on 2016-04-27, Business scope includes technology development,Technology Promotion,technology transfer,technical consulting,Technical Services;Natural science research and experimental development;Engineering and Technology Research and Experimental Development;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Economic and Trade Consulting;market survey;buisness planning;health management(Except for medical treatment activities subject to approval);Health Advisory(Except for medical treatment activities subject to approval).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis. The company was founded in 2019 and is based in New York.

Shanghai Maishi Biotechnology Co., Ltd., established on 2018-05-04, Business scope includes biotechnology,Technology development in the field of medical technology,technology transfer,technical consulting,Technical Services,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,civilian explosives,precursor chemicals),Research and development of biological reagents for non-clinical diagnosis,Sales,Engaged in the import and export of goods and technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.]

Shenzhen Chuangshi Biomedical Co., Ltd., established on 2019-08-07, Business scope includes general business items:Biotechnology Extension Services;Import and export;Technology Import and Export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:pharmaceutical production;sales of medicines.

Dashi Pharmaceutical (Guangdong) Co., Ltd., established on 2017-08-22, Business scope includes biotechnology extension services;Sales:laboratory equipment,Instrumentation;Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval)(The above business scope involves the import and export of goods,Technology Import and Export).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mercedes-Benz Versicherung AG, part of Mercedes-Benz Group AG, is a German company located in Stuttgart that provides insurance services. Gerd Kaiser is the current CEO of the firm.

Robert Bosch GmbH engages in the development of the engineering and electronics sector. Its business sectors include; mobility solutions, industrial technology, consumer goods, and energy and building technology. The company was founded by Robert Bosch in 1886 and is headquartered in Gerlingen-Schillerhöhe, Germany.

TonenGeneral Sekiyu K.K. is a Japan-based company engaged in the import, transportation, refining, manufacture and sale of crude oil, petroleum products and petrochemical products, among others. The Company has two business segments. The Petroleum segment is engaged in the production, processing and sale of petroleum products, the transportation of crude oil and petroleum products, the purchase and sale of liquefied natural gas (LNG), the procurement and sale of biomass fuels, as well as the holding of shares. The Petrochemical Product segment is involved in the production, processing and sale of petrochemical products.

Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2018, the company's largest selling product lines were Neulasta, an immunostimulator used to prevent infections in patients undergoing cancer chemotherapy and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases. Other products include Epogen, Aranesp, Sensipar/Mimpara, Nplate, Vectibix, Prolia and XGEVA.

Shenzhen Wuweihuasi Biotechnology Co., Ltd., established on 2016-06-30, Business scope includes general business items:Technical research and development of biological products and biotechnology products,technical consulting,Technology Transfer and Technical Services(Free of restricted and prohibited items,Involving license management and other special regulation management,Operate only after obtaining a license);commission agent(Does not include auction),Import and export and other supporting business(Commodities that do not involve state trade management,Quota involved,Commodities managed by license management and other special regulations,Apply in accordance with relevant national regulations);Domestic and foreign trade.,The licensing program is:Ι,II,Class III medical device(Contains in vitro diagnostic reagents)with chemical reagents(except dangerous goods)and biochemicals(non-toxic,Hazardous Chemicals)R&D, production and sales.

Ever Supreme Bio Technology Co., Ltd. engages in the research, development, and sale of stem cell products. It also offers immune cell technology and products, new drugs research, and specific cellular therapeutic technology. The company was founded on December 6, 2016 and is headquartered in Taichung, Taiwan.

Part of Merck & Co., Inc., Schering-Plough Animal Health Corp. is an American company located in Union, NJ, that develops and manufatures pharmaceutical and biological products for food producing animals.

Tianjin Lanrui Biotechnology Co., Ltd., established on 2011-09-16, Business scope includes biotechnology development,consult,Serve,transfer;Wholesale and retail trade;biological kit,water treatment agent,Organic Fertilizer and Microbial Fertilizer,biologics(Dangerous goods and precursor drugs are excluded)Production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)